Current issue Volume 15(2); April 2024
-
The COVID-19 Vaccine Safety Research Center: a cornerstone for strengthening safety evidence for COVID-19 vaccination in the Republic of Korea
Na-Young Jeong, Hyesook Park, Sanghoon Oh, Seung Eun Jung, Dong-Hyun Kim, et al.
Osong Public Health Res Perspect. 2024;15(2):97-106.
Special ArticleApril 4, 2024
-
Psychiatric adverse events associated with the COVID-19 vaccines approved in the Republic of Korea: a systematic review
Seungeun Ryoo, Miyoung Choi, Nam-Kyong Choi, Hyoung-Shik Shin, Jun Hee Woo, et al.
Osong Public Health Res Perspect. 2024;15(2):107-114.
Review ArticleMarch 28, 2024
-
AI-powered COVID-19 forecasting: a comprehensive comparison of advanced deep learning methods
Muhammad Usman Tariq, Shuhaida Binti Ismail
Osong Public Health Res Perspect. 2024;15(2):115-136.
Original ArticleMarch 28, 2024
-
Effect of Paxlovid in COVID-19 treatment during the periods of SARS-CoV-2 Omicron BA.5 and BN.1 subvariant dominance in the Republic of Korea: a retrospective cohort study
Dong-Hwi Kim, Min-Gyu Yoo, Na-Young Kim, So Young Choi, Minjeong Jang, et al.
Osong Public Health Res Perspect. 2024;15(2):137-149.
Original ArticleMarch 28, 2024
-
COVID-19 infection among people with disabilities in 2021 prior to the Omicron-dominant period in the Republic of Korea: a cross-sectional study
Seul-Ki Kang, Bryan Inho Kim
Osong Public Health Res Perspect. 2024;15(2):150-158.
Original ArticleMarch 28, 2024
-
Factors associated with the timely diagnosis of malaria and the utilization of types of healthcare facilities: a retrospective study in the Republic of Korea
HyunJung Kim, Sangwoo Tak, So-dam Lee, Seongwoo Park, Kyungwon Hwang
Osong Public Health Res Perspect. 2024;15(2):159-167.
Original ArticleApril 16, 2024
-
Gender differences in hepatitis A seropositivity rates according to the Republic of Korea’s vaccination policy
Hyunjin Son, Sunhyun Ahn, Wonseo Park, Gayoung Chun, Unyeong Go, et al.
Osong Public Health Res Perspect. 2024;15(2):168-173.
Brief ReportApril 16, 2024
-
Establishment of a registry of clinical data and bioresources for rare nervous system diseases
Dayoung Kim, Sooyoung Kim, Jin Myoung Seok, Kyong Jin Shin, Eungseok Oh, et al.
Osong Public Health Res Perspect. 2024;15(2):174-181.
Data ProfileApril 30, 2024
-
Challenges in capacity building of national immunization programs and emergency or pandemic vaccination responses in the Global Health Security Agenda member countries
Sookhyun Lee, Jung Ju Oh, Sang Hyun Park, Dasol Ro, Ye Jin Jeong, et al.
Osong Public Health Res Perspect. 2024;15(2):182-185.
CommentaryMarch 28, 2024
-
EditorialApr 30, 2024
Peacetime preparedness for the vaccine adverse event
Jong-Koo Lee
Osong Public Health Res Perspect. 2024;15(2):95-96.
-
Special ArticleApr 4, 2024
The COVID-19 Vaccine Safety Research Center: a cornerstone for strengthening safety evidence for COVID-19 vaccination in the Republic of Korea
Na-Young Jeong, Hyesook Park, Sanghoon Oh, et al.
Osong Public Health Res Perspect. 2024;15(2):97-106.
-
Review ArticleMar 28, 2024
Psychiatric adverse events associated with the COVID-19 vaccines approved in the Republic of Korea: a systematic review
Seungeun Ryoo, Miyoung Choi, Nam-Kyong Choi, et al.
Osong Public Health Res Perspect. 2024;15(2):107-114.
-
Original ArticleMar 28, 2024
AI-powered COVID-19 forecasting: a comprehensive comparison of advanced deep learning methods
Muhammad Usman Tariq, Shuhaida Binti Ismail
Osong Public Health Res Perspect. 2024;15(2):115-136.
-
Original ArticleMar 28, 2024
Effect of Paxlovid in COVID-19 treatment during the periods of SARS-CoV-2 Omicron BA.5 and BN.1 subvariant dominance in the Republic of Korea: a retrospective cohort study
Dong-Hwi Kim, Min-Gyu Yoo, Na-Young Kim, et al.
Osong Public Health Res Perspect. 2024;15(2):137-149.
-
Original ArticleMar 28, 2024
COVID-19 infection among people with disabilities in 2021 prior to the Omicron-dominant period in the Republic of Korea: a cross-sectional study
Seul-Ki Kang, Bryan Inho Kim
Osong Public Health Res Perspect. 2024;15(2):150-158.